CNBC

Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance

6 5 月, 2026

One Min Read

5 Views

Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.

原文: https://www.cnbc.com/2026/05/06/wegovy-glp1-weight-loss-novo-nordisk-earnings-stock-nvo-ozempic.html

Last Update: 6 5 月, 2026

Written By

Other Articles

Previous

【外圍經濟】韓國第一季出口近2200億美元創歷史新高，晶片出口上漲139%

Next

【ＡＩ】黃仁勳確認英偉達在華ＡＩ加速器市場份額降至０％

Related Posts

Retail investors are running head first into this topsy-turvy market

1 Min Read

Third Point, D.E. Shaw obtain agreements with CoStar. How the activists can build value

1 Min Read

Top Wall Street analysts find these 3 stocks attractive in these challenging times

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept